{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:44:53Z","timestamp":1793256293224,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004315","name":"GlaxoSmithKline USA Rockville","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["209698"],"award-info":[{"award-number":["209698"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.japh.2021.09.010","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T16:59:18Z","timestamp":1632934758000},"page":"95-103.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The impact of community pharmacy utilization of immunization information systems on vaccination rates: Results of a clustered randomized controlled trial"],"prefix":"10.1016","volume":"62","author":[{"given":"Pamela C.","family":"Heaton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy","family":"Altstadter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmina","family":"Hogea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Poston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinaz","family":"Ghaswalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.japh.2021.09.010_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/21645515.2018.1558689","article-title":"Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live","volume":"15","author":"Curran","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.japh.2021.09.010_bib2","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1377\/hlthaff.2016.0462","article-title":"Modeling the economic burden of adult vaccine-preventable diseases in the United States","volume":"35","author":"Ozawa","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.japh.2021.09.010_bib9","unstructured":"United States Department of Health and Human Services. Guidance for Licensed Pharmacists and Pharmacy Interns regarding COVID-19 Vaccines and Immunity under the PREP Act; 2020. United States Government."},{"key":"10.1016\/j.japh.2021.09.010_bib10","series-title":"Pharmacies: A Vital Partner in","year":"2020"},{"key":"10.1016\/j.japh.2021.09.010_bib13","unstructured":"Centers for Disease Control and Prevention. Progress in immunization information systems \u2013 United States, 2012. MMWR. 2013;62(49):1005\u20131008."},{"key":"10.1016\/j.japh.2021.09.010_bib14","article-title":"Adult influenza vaccinations reported to the Wisconsin Immunization Registry by Retail Pharmacies, 2011\u20132014","volume":"2013","author":"Petit","year":"2015","journal-title":"Pharm Pract"},{"issue":"45","key":"10.1016\/j.japh.2021.09.010_bib15","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1016\/j.vaccine.2018.09.024","article-title":"U.S. Clinicians' and pharmacists' reported barriers to implementation of the standards for adult immunization practice","volume":"36","author":"Srivastav","year":"2018","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.japh.2021.09.010_bib16","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1016\/j.vaccine.2018.07.027","article-title":"National survey of pharmacy-based immunization services","volume":"36","author":"Westrick","year":"2018","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.japh.2021.09.010_bib17","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1097\/PHH.0b013e3181cbc4ec","article-title":"Immunization information system opt-in consent: at what cost?","volume":"16","author":"Boom","year":"2010","journal-title":"J\u00a0Public Health Manag Pract"},{"key":"10.1016\/j.japh.2021.09.010_bib18","series-title":"Vaccines National Stategic Plan for the United States (2021\u20132025)","year":"2021"},{"issue":"1","key":"10.1016\/j.japh.2021.09.010_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/pop.2017.0049","article-title":"Evaluation of the impact of an innovative immunization practice model designed to improve population health: results of the project IMPACT immunizations pilot","volume":"21","author":"Bluml","year":"2018","journal-title":"Popul Health Manag"},{"issue":"1","key":"10.1016\/j.japh.2021.09.010_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vaccine.2018.11.043","article-title":"Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates","volume":"37","author":"Wehbi","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.japh.2021.09.010_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.vaccine.2018.11.018","article-title":"The effects of vaccination forecasts and value-based payment on adult immunizations by community pharmacists","volume":"37","author":"Bacci","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.japh.2021.09.010_bib22","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.japh.2018.04.003","article-title":"Comparison of two training methods in community pharmacy: project VACCINATE","volume":"58","author":"Lin","year":"2018","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"9","key":"10.1016\/j.japh.2021.09.010_bib23","first-page":"989","article-title":"Effect of automated immunization registry-based telephonic interventions on adult vaccination rates in community pharmacies: a randomized controlled trial","volume":"25","author":"Stolpe","year":"2019","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.japh.2021.09.010_bib25","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.japh.2020.08.036","article-title":"Enhancing adult immunization care by community pharmacists: A qualitative analysis of project VACCINATE","volume":"61","author":"Tran","year":"2021","journal-title":"J.\u00a0Am. Pharm. Assoc. (2003)"},{"issue":"4","key":"10.1016\/j.japh.2021.09.010_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.37901\/jcphp17-00006","article-title":"A\u00a0guide to the California Immunization Registry and its use to enhance the delivery of immunization services","volume":"64","author":"Bach","year":"2017","journal-title":"J.\u00a0Contemp. Pharm. Pract"},{"issue":"3","key":"10.1016\/j.japh.2021.09.010_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"370","key":"10.1016\/j.japh.2021.09.010_bib28","first-page":"1","article-title":"Shingles vaccination among adults aged 60 and over: United States, 2018","volume":"370","author":"Terlizzi","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"46","key":"10.1016\/j.japh.2021.09.010_bib29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.japh.2021.09.010_bib31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.amepre.2014.12.008","article-title":"Impact of health insurance status on vaccination coverage among adult populations","volume":"48","author":"Lu","year":"2015","journal-title":"Am J Prev Med"},{"issue":"9609","key":"10.1016\/j.japh.2021.09.010_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(07)61835-2","article-title":"CONSORT for reporting randomised trials in journal and conference abstracts","volume":"371","author":"Hopewell","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.japh.2021.09.010_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050020","article-title":"CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration","volume":"5","author":"Hopewell","year":"2008","journal-title":"PLOS Med"},{"issue":"10","key":"10.1016\/j.japh.2021.09.010_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121003800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121003800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:49:13Z","timestamp":1761544153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319121003800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1544319121003800"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2021.09.010","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of community pharmacy utilization of immunization information systems on vaccination rates: Results of a clustered randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2021.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}